Pham Quang X 4
4 · Cadrenal Therapeutics, Inc. · Filed Jan 24, 2025
Insider Transaction Report
Form 4
Pham Quang X
DirectorCEO and Chairman10% Owner
Transactions
- Award
Stock Options
2025-01-23+65,000→ 65,000 totalExercise: $21.77From: 2026-02-01Exp: 2030-01-22→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]Consists of options to purchase 65,000 shares of common stock, which shall vest 1/4 on February 1, 2026 and thereafter pro rata on a monthly basis over three years, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to 110% of the fair market value of the Issuer's common stock on the effective date of the grant.